CORPOMIN Trademark

Trademark Overview


On Tuesday, November 1, 2011, a trademark application was filed for CORPOMIN with the United States Patent and Trademark Office. The USPTO has given the CORPOMIN trademark a serial number of 85461190. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 11, 2016. This trademark is owned by Eli Lilly and Company. The CORPOMIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants
corpomin

General Information


Serial Number85461190
Word MarkCORPOMIN
Filing DateTuesday, November 1, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 11, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 7, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, January 11, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 11, 2016ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 22, 2015EXTENSION 5 GRANTED
Friday, May 15, 2015EXTENSION 5 FILED
Friday, May 15, 2015TEAS EXTENSION RECEIVED
Tuesday, December 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 1, 2014EXTENSION 4 GRANTED
Friday, November 7, 2014EXTENSION 4 FILED
Friday, November 7, 2014TEAS EXTENSION RECEIVED
Wednesday, June 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 3, 2014EXTENSION 3 GRANTED
Tuesday, May 20, 2014EXTENSION 3 FILED
Tuesday, May 20, 2014TEAS EXTENSION RECEIVED
Wednesday, November 27, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 26, 2013EXTENSION 2 GRANTED
Tuesday, November 19, 2013EXTENSION 2 FILED
Tuesday, November 19, 2013TEAS EXTENSION RECEIVED
Thursday, May 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2013EXTENSION 1 GRANTED
Wednesday, April 24, 2013EXTENSION 1 FILED
Tuesday, May 21, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 24, 2013TEAS EXTENSION RECEIVED
Tuesday, December 11, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 16, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2012PUBLISHED FOR OPPOSITION
Wednesday, September 26, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 12, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 11, 2012ASSIGNED TO LIE
Thursday, August 30, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 6, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 6, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 6, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 8, 2012NOTIFICATION OF PRIORITY ACTION E-MAILED
Sunday, January 8, 2012PRIORITY ACTION E-MAILED
Sunday, January 8, 2012PRIORITY ACTION WRITTEN
Tuesday, December 13, 2011ASSIGNED TO EXAMINER
Monday, November 7, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 4, 2011NEW APPLICATION ENTERED IN TRAM